Tempus ECG-AF vs AHI System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tempus ECG-AF is designed for long-term risk prediction of atrial fibrillation in specific patient populations, utilizing 12-lead ECG recordings for earlier identification and follow-up. Conversely, Fifth Eye's AHI System offers real-time predictive analytics for acute hemodynamic instability, using continuous Lead II ECG signals to detect patient deterioration hours before vital signs. While both leverage AI and ECG data, their distinct clinical targets and time horizons make them suitable for different phases of patient care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-AF is designed to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. The AHI System provides real-time predictive analytics for hemodynamic instability, detecting patient deterioration hours before vital signs change.
Tempus ECG-AF analyzes 12-lead ECG recordings to identify risk factors for AF. In contrast, the AHI System utilizes continuous Lead II ECG signals for its real-time predictive analytics of hemodynamic instability.
Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. The AHI System is geared towards patients requiring continuous monitoring, particularly in critical care, emergency medicine, and hospital medicine settings, for early detection of hemodynamic instability.
Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms, compatible with FDA authorized resting 12-lead ECGs from GE and Philips. The AHI System is a software-only device that integrates with existing hospital IT infrastructure and patient monitoring platforms like Sickbay and VitalConnect.
Yes, Tempus ECG-AF has CMS reimbursement available under CPT 0764T and CPT 0765T, mapping to APC 5734, with a Medicare rate of $128.90 effective January 1, 2025. The provided information for the AHI System does not specify any particular reimbursement codes.
Tempus ECG-AF is primarily relevant for Cardiology, Geriatrics, and Internal Medicine due to its focus on AF risk in older adults. The AHI System is most beneficial for Critical Care, Emergency Medicine, and Hospital Medicine, given its application in predicting hemodynamic instability.
Tempus ECG-AF provides an AI-based assessment of increased risk for developing new-onset AF within 12 months, intended to support earlier identification and follow-up. The AHI System offers real-time predictive analytics and early warnings for hemodynamic instability, hours ahead of vital signs, serving as adjunctive clinical decision support.